Gilead Sciences Stock Performance (24 Hours)
- Price change: +2.36 % during the 24‑hour period ending 05:24 AM Central Europe on Saturday, 24 th.
- Current price: USD 156.04.
- Shares outstanding: 1.2 bn.
- Market capitalization: USD 190.4 bn.
- Volume traded in last 24 hours: USD 976.2 mn.
- Month‑end change: +3.84 %.
- 200‑day simple moving average: USD 138.71.
- 52‑week high: USD 160.51 (15 Oct 2026).
- 52‑week low: USD 114.02 (31 Oct 2025).
Related Stock Performance (24 Hours)
| Ticker | Price change | Current price (USD) | Market capitalization (USD bn) | P/E ratio |
|---|---|---|---|---|
| CRM (Salesforce) | +3.52 % | 248.57 | 199 | 22.03 |
| C (Citigroup) | –1.08 % | 120.62 | 205 | 12.08 |
| SNDK (SanDisk) | –8.51 % | 1,238.03 | 201.8 | 18.74 |
| DIS (Walt Disney) | 0 % | 112.52 | 193.1 | 23.07 |
| APH (Amphenol) | –7.74 % | 74.09 | 195.3 | 39.65 |
Company Overview
Gilead Sciences, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of therapies for life‑threatening diseases. Its research portfolio includes HIV, AIDS, liver disease, and significant cardiovascular and respiratory conditions. The company went public on January 22 , 1992 and is listed on Nasdaq.
For additional information, visit the company’s website at www.gilead.com .
